Alain Mina

411 total citations
31 papers, 201 citations indexed

About

Alain Mina is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Alain Mina has authored 31 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Alain Mina's work include Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Histone Deacetylase Inhibitors Research (4 papers). Alain Mina is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Histone Deacetylase Inhibitors Research (4 papers). Alain Mina collaborates with scholars based in United States, Lebanon and Hungary. Alain Mina's co-authors include Rachel Yoder, Priyanka Sharma, Leonidas C. Platanias, Koen van Besien, Barbara Pro, Arafat Tfayli, Jessica K. Altman, Hind Rafei, Michael Heuser and Madina Sukhanova and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Alain Mina

26 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alain Mina United States 9 70 69 49 47 40 31 201
Shanbo Cao China 9 68 1.0× 74 1.1× 77 1.6× 40 0.9× 61 1.5× 46 219
Eric S. Schafer United States 11 92 1.3× 115 1.7× 43 0.9× 95 2.0× 19 0.5× 36 391
Rebecca Brown United States 9 59 0.8× 80 1.2× 34 0.7× 15 0.3× 38 0.9× 14 325
Amit Pande United States 6 105 1.5× 76 1.1× 43 0.9× 18 0.4× 23 0.6× 27 234
Elva Jiménez‐Hernández Mexico 10 95 1.4× 95 1.4× 18 0.4× 79 1.7× 47 1.2× 33 312
Tsuneaki Hirakawa Japan 6 83 1.2× 52 0.8× 21 0.4× 98 2.1× 21 0.5× 20 248
Christoph Busemann Germany 10 98 1.4× 53 0.8× 61 1.2× 80 1.7× 13 0.3× 28 299
Elizabeth H. Cull United States 9 100 1.4× 101 1.5× 16 0.3× 117 2.5× 21 0.5× 27 272
Uta Brunnberg Germany 10 133 1.9× 106 1.5× 29 0.6× 94 2.0× 19 0.5× 23 345
Maliha Nusrat United States 7 138 2.0× 56 0.8× 30 0.6× 28 0.6× 40 1.0× 20 213

Countries citing papers authored by Alain Mina

Since Specialization
Citations

This map shows the geographic impact of Alain Mina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Mina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Mina more than expected).

Fields of papers citing papers by Alain Mina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Mina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Mina. The network helps show where Alain Mina may publish in the future.

Co-authorship network of co-authors of Alain Mina

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Mina. A scholar is included among the top collaborators of Alain Mina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Mina. Alain Mina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoff, Fieke W., Eduard Schulz, Steven Z. Pavletic, & Alain Mina. (2025). Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance. Blood Reviews. 74. 101319–101319.
2.
Jurdi, Najla El, Noa G. Holtzman, Alain Mina, et al.. (2025). A phase 2 study of single agent ibrutinib for first‐line treatment of chronic graft‐versus‐host disease: A new paradigm and lessons learned. British Journal of Haematology. 206(6). 1822–1827. 1 indexed citations
3.
Schulz, Eduard, Steven Z. Pavletic, & Alain Mina. (2024). Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges. Seminars in Hematology. 61(6). 420–430.
4.
Mendoza, Tito R., Amanda King, Elizabeth Vera, et al.. (2024). Patient-reported outcomes in early phase trials for patients with myelodysplastic syndromes. Seminars in Hematology. 61(6). 457–464.
5.
Mina, Alain, Peter L. Greenberg, & H. Joachim Deeg. (2024). How I reduce and treat posttransplant relapse of MDS. Blood. 143(14). 1344–1354. 6 indexed citations
6.
Mina, Alain, Steven Z. Pavletic, & Peter D. Aplan. (2024). The evolution of preclinical models for myelodysplastic neoplasms. Leukemia. 38(4). 683–691. 4 indexed citations
7.
Schulz, Eduard, et al.. (2024). Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes. Seminars in Hematology. 61(6). 348–357.
8.
Steinberg, Seth M., Noa G. Holtzman, Eduard Schulz, et al.. (2023). Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease. Bone Marrow Transplantation. 58(12). 1377–1383. 1 indexed citations
9.
Mina, Alain & Barbara Pro. (2021). T time: Emerging and new therapies for peripheral T-cell lymphoma. Blood Reviews. 52. 100889–100889. 10 indexed citations
10.
Mina, Alain, Ewa M. Kościuczuk, Shira Dinner, et al.. (2021). Inhibitory effects of Tomivosertib in acute myeloid leukemia. Oncotarget. 12(10). 955–966. 6 indexed citations
11.
Gao, Juehua, Alain Mina, Jessica K. Altman, et al.. (2020). Unique morphologic and genetic characteristics of acute myeloid leukemia with chromothripsis: a clinicopathologic study from a single institution. Human Pathology. 98. 22–31. 11 indexed citations
12.
Mina, Alain, Koen van Besien, & Leonidas C. Platanias. (2020). Hematological manifestations of COVID-19. Leukemia & lymphoma. 61(12). 2790–2798. 28 indexed citations
13.
Zhang, Yanming, Alain Mina, Jessica K. Altman, et al.. (2019). An integrative approach reveals genetic complexity and epigenetic perturbation in acute promyelocytic leukemia: a single institution experience. Human Pathology. 91. 1–10. 5 indexed citations
14.
Mina, Alain & Brady L. Stein. (2019). Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?. Current Hematologic Malignancy Reports. 14(3). 137–144. 2 indexed citations
15.
Mina, Alain, Leyla Shune, Haitham Abdelhakim, et al.. (2018). Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment. Annals of Hematology. 98(2). 481–489. 3 indexed citations
16.
Mina, Alain, et al.. (2017). Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?. Blood Reviews. 32(2). 159–166. 10 indexed citations
17.
Mina, Alain, Rachel Yoder, & Priyanka Sharma. (2017). Targeting the androgen receptor in triple-negative breast cancer: current perspectives. OncoTargets and Therapy. Volume 10. 4675–4685. 48 indexed citations
18.
Tfayli, Arafat, Alain Mina, Hind Rafei, et al.. (2015). Screening for the Prevalence of EGFR and Alk Mutations in Lung Adenocarcinoma Patients in the Levant Area, a Prospective Analysis. Annals of Oncology. 26. i1–i1. 1 indexed citations
19.
Mina, Alain, et al.. (2015). Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients. BMC Cancer. 15(1). 10–10. 11 indexed citations
20.
Mina, Alain, et al.. (2005). Results of a Multilateral Approach to Donation–Transplantation Process in Hungary in the Past 2 Years. Transplantation Proceedings. 37(8). 3260–3261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanbo Cao Breakdown of academic impact, for papers by Eric S. Schafer Breakdown of academic impact, for papers by Rebecca Brown Breakdown of academic impact, for papers by Amit Pande Breakdown of academic impact, for papers by Elva Jiménez‐Hernández Breakdown of academic impact, for papers by Tsuneaki Hirakawa Breakdown of academic impact, for papers by Christoph Busemann Breakdown of academic impact, for papers by Elizabeth H. Cull Breakdown of academic impact, for papers by Uta Brunnberg Breakdown of academic impact, for papers by Maliha Nusrat
Rankless by CCL
2026